期刊文献+
共找到188篇文章
< 1 2 10 >
每页显示 20 50 100
Cancerous inhibitor of protein phosphatase 2A enhances chemoresistance of gastric cancer cells to oxaliplatin
1
作者 Yong-Xun Zhao Li-Bin Ma +3 位作者 Ze Yang Fang Wang Hui-Ying Wang Jia-Yao Dang 《World Journal of Gastrointestinal Oncology》 SCIE 2023年第2期286-302,共17页
BACKGROUND Cancerous inhibitor of protein phosphatase 2A(CIP2A)is a newly discovered oncogene.It is an active cell proliferation regulatory factor that inhibits tumor apoptosis in gastric cancer(GC)cells.CIP2A is func... BACKGROUND Cancerous inhibitor of protein phosphatase 2A(CIP2A)is a newly discovered oncogene.It is an active cell proliferation regulatory factor that inhibits tumor apoptosis in gastric cancer(GC)cells.CIP2A is functionally related to chemoresistance in various types of tumors according to recent studies.The underlying mechanism,however,is unknown.Further,the primary treatment regimen for GC is oxaliplatin-based chemotherapy.Nonetheless,it often fails due to chemoresistance of GC cells to oxaliplatin.AIM The goal of this study was to examine CIP2A expression and its association with oxaliplatin resistance in human GC cells.METHODS Immunohistochemistry was used to examine CIP2A expression in GC tissues and adjacent normal tissues.CIP2A expression in GC cell lines was reduced using small interfering RNA.After confirming the silencing efficiency,3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide tetrazolium and flow cytometry assays were used to evaluate cell proliferation and apoptosis caused by oxaliplatin treatment.Further,the key genes and protein changes were verified using realtime quantitative reverse transcription PCR and Western blotting,respectively,before and after intervention.For bioinformatics analysis,we used the R software and Bioconductor project.For statistical analysis,we used GraphPad Prism 6.0 and the Statistical Package for the Social Sciences software version 20.0(IBM,Armonk,United States).RESULTS A high level of CIP2A expression was associated with tumor size,T stage,lymph node metastasis,Tumor Node Metastasis stage,and a poor prognosis.Further,CIP2A expression was higher in GC cells than in normal human gastric epithelial cells.Using small interfering RNA against CIP2A,we discovered that CIP2A knockdown inhibited cell proliferation and significantly increased GC cell sensitivity to oxaliplatin.Moreover,CIP2A knockdown enhanced oxaliplatin-induced apoptosis in GC cells.Hence,high CIP2A levels in GC may be a factor in chemoresistance to oxaliplatin.In human GC cells,CIP2A regulated protein kinase B phosphorylation,and chemical inhibition of the protein kinase B signaling pathway was significantly associated with increased sensitivity to oxaliplatin.Therefore,the protein kinase B signaling pathway was correlated with CIP2Aenhanced chemoresistance of human GC cells to oxaliplatin.CONCLUSION CIP2A expression could be a novel therapeutic strategy for chemoresistance in GC. 展开更多
关键词 cancerous inhibitor of protein phosphatase 2a Gastric cancer OXALIPLATIN CHEMORESISTANCE AKT
下载PDF
PP2A Inhibits Cervical Cancer Cell Migration by Dephosphorylation of p-JNK,p-p38 and the p-ERK/MAPK Signaling Pathway 被引量:15
2
作者 Hong-yun ZHENG Fu-jin SHEN +1 位作者 Yong-qing TONG Yan LI 《Journal of Huazhong University of Science and Technology(Medical Sciences)》 SCIE CAS 2018年第1期115-123,共9页
Protein phosphatase 2 A(PP2 A) was reported to play an important role in cancer development;however,the relationship between PP2 A and cervical cancer development has yet to be fully understood.The present study aim... Protein phosphatase 2 A(PP2 A) was reported to play an important role in cancer development;however,the relationship between PP2 A and cervical cancer development has yet to be fully understood.The present study aimed to explore the role of PP2 A in the development of cervical cancer.Serum levels of PP2 A were detected by ELISA in 23 patients with cervical cancer and 30 patients with benign cervical lesions.Furthermore,the PP2 A activities and the m RNA and protein levels of PP2 A were measured in cervical cancer(n=8) and chronic cervicitis(n=10) tissues.The results showed that the serum levels of PP2 A were significantly reduced in patients with cervical cancer.Further studies showed that not only the activities of PP2 A but also the m RNA and protein levels of PP2 A were significantly decreased in cervical cancer tissues.Wound healing and Transwell assays demonstrated that pharmacological and genetic upregulation of PP2 A could inhibit the migration of He La cells,but the downregulation of PP2 A promoted cellular migration.The activation of PP2 A also inhibited the remodeling of actin and the activity of mitogen-activated protein kinases(MAPKs) including p-JNK,p-p38 and p-ERK.Meanwhile,the activation of PP2 A was found to downregulate MMP-9 levels,which further inhibited the migration and invasion of He La cells.In conclusion,our data suggest that the activity and expression of PP2 A are significantly reduced in cervical cancer tissues,and the activation of PP2 A may inhibit the migration of cervical cancer cells by inhibiting the phosphorylation of p-JNK,p-p38 and the p-ERK/MAPK signaling pathway as well as by downregulating MMP-9,implying that PP2 A plays an important role in cervical cancer development. 展开更多
关键词 protein phosphatase 2a HeLa cells migration mitogen-activated protein kinases
下载PDF
Ca2+/calmodulin-dependent protein kinase II regulates colon cancer proliferation and migration via ERK1/2 and p38 pathways 被引量:8
3
作者 Wei Chen Ping An +4 位作者 Xiao-Jing Quan Jun Zhang Zhong-Yin Zhou Li-Ping Zou He-Sheng Luo 《World Journal of Gastroenterology》 SCIE CAS 2017年第33期6111-6118,共8页
AIM To investigate the role of calmodulin-dependent protein kinase Ⅱ(Ca MKⅡ) in colon cancer growth,migration and invasion.METHODS Ca MKⅡ expression in colon cancer and paracancerous tissues was evaluated via immun... AIM To investigate the role of calmodulin-dependent protein kinase Ⅱ(Ca MKⅡ) in colon cancer growth,migration and invasion.METHODS Ca MKⅡ expression in colon cancer and paracancerous tissues was evaluated via immunochemistry. Transcriptional and posttranscriptional levels of Ca MKⅡin tissue samples and MMP2,MMP9 and TIMP-1 expression in the human colon cancer cell line HCT116 were assessed by q RTPCR and western blot. Cell proliferation was detected with the MTT assay. Cancer cell migration and invasion were investigated with the Transwell culture system and woundhealing assay.RESULTS We first demonstrated that CaMK Ⅱ was ove rexpressed in human colon cancers and was associated with cancer differentiation. In the human colon cancer cell line HCT116,the Ca MKII-specific inhibitor KN93,but not its inactive analogue KN92,decreased cancer cell proliferation. Furthermore,KN93 also significantly prohibited HCT116 cell migration and invasion. The specific inhibition of ERK1/2 or p38 decreased the proliferation and migration of colon cancer cells.CONCLUSION Our findings highlight Ca MKⅡ as a potential critical mediator in human colon tumor development and metastasis. 展开更多
关键词 Ca2+/calmodulin-dependent protein kinase II Colon cancer PROLIFERATION migration
下载PDF
Expression and Significance of SHP-2 in Human Papillomavirus Infected Cervical Cancer 被引量:4
4
作者 孟斐 赵晓云2 张淑兰 《Journal of Huazhong University of Science and Technology(Medical Sciences)》 SCIE CAS 2012年第2期247-251,共5页
This study investigated the expression and prognostic value of SHP-2 in cervical cancer caused by human papillomavirus (HPV) infection. Forty-five specimens from patients with cervical cancer (stageⅠ-Ⅲ), 32 specimen... This study investigated the expression and prognostic value of SHP-2 in cervical cancer caused by human papillomavirus (HPV) infection. Forty-five specimens from patients with cervical cancer (stageⅠ-Ⅲ), 32 specimens from patients with cervical intraepithelial neoplasia (CIN) (Ⅰ, Ⅱ) and 20 normal cervical samples from patients with hysteromyoma were collected in Department of Pathology for comparison. The expression levels of SHP-2 and IFN-β proteins were detected by using immunohistochemistry. The mRNA expression level of SHP-2 was detected by using quantitative real-time polymerase chain reaction (PCR). HPVs were detected by HPV GenoArray Test. The Spearman correlation was used to compare the expression level of SHP-2 in HPV infected cervical cancer vs non-HPV infected normal cervix. The level of SHP-2 protein expression in the cancer tissues (88.8%) was significantly higher than in CIN tissues (62.5%) and normal cervixes (45%) (P<0.05 and P<0.05, respectively). The SHP-2 mRNA levels in the cancer tissues were upregulated as compared with those in the normal cervixes (P<0.05). Twenty-one (46.7%) cervical cancers, 25 (78.1%) CINs and 17 (85%) normal cervixes showed IFN-β positive staining in cytoplasm. There was statistically significant difference in the expression rate of IFN-β between cervical cancer and normal cervix (χ2=8.378, P<0.05) as well as between cervical cancer and CIN (χ2=7.695, P<0.05). HPV16/18 infections could be found in normal cervixs (15%), CINs (68.7%) and cervical cancers (84.4%). There was a correlation between HPV infection and SHP-2 expression in cervical cancer (rs=0.653, P<0.05). SHP-2 may be a useful prognostic and diagnostic indicator for HPV infected cervical cancer. In cervical cancers, SHP-2 mRNA and protein overexpression was associated with IFN-β lower-expression. 展开更多
关键词 cervical cancer cervical intraepithelial neoplasia human papillomavirus SH2-containing protein tyrosine phosphatase 2 type interferon β
下载PDF
Increased expression of tyrosine phosphatase SHP-2 in Helicobacter pylori-infected gastric cancer 被引量:3
5
作者 Jing Jiang Mei-Shan Jin +6 位作者 Fei Kong Yin-Ping Wang Zhi-Fang Jia Dong-Hui Cao Hong-Xi Ma Jian Suo Xue-Yuan Cao 《World Journal of Gastroenterology》 SCIE CAS 2013年第4期575-580,共6页
AIM:To explore the alteration of tyrosine phosphatase SHP-2 protein expression in gastric cancer and to assess its prognostic values.METHODS:Three hundred and five consecutive cases of gastric cancer were enrolled int... AIM:To explore the alteration of tyrosine phosphatase SHP-2 protein expression in gastric cancer and to assess its prognostic values.METHODS:Three hundred and five consecutive cases of gastric cancer were enrolled into this study.SHP-2 expression was carried out in 305 gastric cancer specimens,of which 83 were paired adjacent normal gastric mucus samples,using a tissue microarray immunohistochemical method.Correlations were analyzed between expression levels of SHP-2 protein and tumor parameters or clinical outcomes.Serum anti-Helicobacter pylori(H.pylori) immunoglobulin G was detected with enzyme-linked immunosorbent assay.Cox proportional hazards model was used to evaluate prognostic values by compassion of the expression levels of SHP-2 and disease-specific survivals in patients.RESULTS:SHP-2 staining was found diffuse mainly in the cytoplasm and the weak staining was also observed in the nucleus in gastric mucosa cells.Thirty-two point five percent of normal epithelial specimen and 62.6% of gastric cancer specimen were identified to stain with SHP-2 antibody positively(P < 0.001).Though SHP-2 staining intensities were stronger in the H.pylori(+) group than in the H.pylori(-) group,no statistically significant difference was found in the expression levels of SHP-2 between H.pylori(+) and H.pylori(-) gastric cancer(P = 0.40).The SHP-2 expression in gastric cancer was not significantly associated with cancer stages,lymph node metastases,and distant metastasis of the tumors(P = 0.34,P = 0.17,P = 0.52).Multivariate analysis demonstrated no correlation between SHP-2 expression and disease-free survival(P = 0.86).CONCLUSION:Increased expression of SHP-2 protein in gastric cancer specimen suggesting the aberrant upregulation of SHP-2 protein might play an important role in the gastric carcinogenesis. 展开更多
关键词 Gastric cancer SH2-containing protein TYROSINE phosphatase 2 Expression HELICOBACTER PYLORI
下载PDF
Correlation of SFRP2 and TPX2 expression with cancer cell apoptosis and EMT process in cervical cancer
6
作者 Chao-Ban Zheng Yu-Ping Li 《Journal of Hainan Medical University》 2018年第1期109-112,共4页
Objective: To study the correlation of SFRP2 and TPX2 expression with cancer cell apoptosis and EMT process in cervical cancer. Methods: Patients with cervical cancer who received surgical resection in No.174 Hospital... Objective: To study the correlation of SFRP2 and TPX2 expression with cancer cell apoptosis and EMT process in cervical cancer. Methods: Patients with cervical cancer who received surgical resection in No.174 Hospital of PLA between June 2015 and December 2016 were selected as the research subjects, moderate amount of cervical cancer lesion and adjacent lesion were collected after surgical resection to extract RNA, and then fluorescent quantitative PCR kit was used to determine the expression of SFRP2, TPX2, apoptosis genes and EMT genes in lesion tissue. Results: SFRP2, SARI, AIF, FHIT, NDRG4, MCPH1 and E-cadherin mRNA expression in cervical cancer lesion were greatly lower than those in adjacent lesions whereas TPX2, SP2, CyclinD1, Piwil2, HERC4, EFEMP1, EZH2, TGF-β1, N-cadherin and Vimentin1 mRNA expression were greatly higher than those in adjacent lesions;SFRP2 mRNA expression in cervical cancer lesion was positively correlated with SARI, AIF, FHIT, NDRG4, MCPH1 and E-cadherin mRNA expression, and negatively correlated with SP2, CyclinD1, Piwil2, HERC4, EFEMP1, EZH2, TGF-β1, N-cadherin and Vimentin1 mRNA expression whereas TPX2 mRNA expression was negatively correlated with SARI, AIF, FHIT, NDRG4, MCPH1 and E-cadherin mRNA expression, and positively correlated with SP2, CyclinD1, Piwil2, HERC4, EFEMP1, EZH2, TGF-β1, N-cadherin and Vimentin1 mRNA expression. Conclusion: The lowly expressed SFRP2 and highly expressed TPX2 in cervical cancer lesions can inhibit the apoptosis of cancer cells and promote the EMT process of cancer cells. 展开更多
关键词 cervical cancer SECRETED frizzled-related protein 2 Targeting protein for Xklp2
下载PDF
基于NOD2介导的AMPK/mTOR信号通路探讨宫颈癌细胞恶性行为的机制
7
作者 杜瑞亭 伍东月 +1 位作者 郭清民 靳冬梅 《安徽医科大学学报》 CAS 北大核心 2024年第2期316-324,共9页
目的 基于核苷酸结合寡聚化结构域受体2(NOD2)介导的AMP活化蛋白激酶(AMPK)/雷帕霉素靶蛋白(mTOR)信号通路探讨宫颈癌(CC)细胞恶性行为的机制。方法 生物信息学分析确定NOD2在CC组织中的表达。将靶向NOD2(shNOD2)、shRNAs阴性对照(shNC... 目的 基于核苷酸结合寡聚化结构域受体2(NOD2)介导的AMP活化蛋白激酶(AMPK)/雷帕霉素靶蛋白(mTOR)信号通路探讨宫颈癌(CC)细胞恶性行为的机制。方法 生物信息学分析确定NOD2在CC组织中的表达。将靶向NOD2(shNOD2)、shRNAs阴性对照(shNC)以及NOD2过表达(NOD2)质粒和载体(Vec)转染CC细胞。通过CCK-8测定、集落形成和Transwell细胞侵袭测定来确定NOD2对CC细胞生长的影响。通过高通量RNA测序(RNA-Seq)进行转录组分析。Western blot试验检测细胞系中NOD2、AMPK/mTOR信号通路和自噬蛋白的表达。24只雌性BALB/c裸鼠随机分为4组,每组6只:载体组(Vec组)、NOD2过表达组(NOD2组)、shNC组和shNOD2组。构建小鼠远处转移模型,监测肺转移的荧光强度,计数肺转移结节的数量。结果 在线数据库分析显示,NOD2在CC组织中表达明显高于正常组织,并且不同分期的CC中NOD2的mRNA表达差异有统计学意义(P<0.05)。此外,NOD2的高表达与较差的总生存期和无病生存期相关(P<0.05)。NOD2过表达对CC细胞增殖、集落形成、迁移和侵袭具有促进作用,而NOD2敲低则相反。与体外结果一致,在转移的小鼠尾静脉注射模型中,NOD2组CC细胞的肺定殖、肺转移灶较Vec组增加(P<0.05),而shNOD2组CC细胞的肺定殖、肺转移灶较shNC组减少(P<0.05)。RNA-Seq结果显示NOD2表达与AMPK信号激活、mTOR信号抑制、自噬调节途径激活和自噬体形成显著相关。与shNC组相比,shNOD2组磷酸化AMPK、LC3蛋白表达水平减少(P<0.05),磷酸化mTOR、p62蛋白表达水平增加(P<0.05);与Vec组相比,NOD2组LC3、AMPK蛋白表达水平增加(P<0.05),磷酸化mTOR、p62蛋白表达水平减少(P<0.05)。与shNC组相比,shNOD2组GFP-mRFP-LC3的点积累减少(P<0.05);与Vec组相比,GFP-mRFP-LC3的点积累增加(P<0.05)。结论 NOD2可能通过AMPK/mTOR信号促进CC增殖、迁移和侵袭,其作用机制部分涉及自噬激活。 展开更多
关键词 核苷酸结合寡聚化结构域受体2 AMP活化蛋白激酶 雷帕霉素靶蛋白 宫颈癌细胞 自噬
下载PDF
Hfgl2在宫颈癌患者组织中的表达及其临床意义
8
作者 江玉 裴美丽 +2 位作者 陈茜 陈刚 邹余粮 《中国妇幼健康研究》 2024年第6期33-40,共8页
目的分析人纤维介素(Hfgl2)在宫颈癌组织中的表达及其意义,探究其对宫颈癌恶性生物学行为的影响。方法选取2016年1月至2018年1月在榆林市第一医院经病理确诊的50例宫颈癌患者的癌组织标本作为实验组,另外收集同期50例正常宫颈组织作为... 目的分析人纤维介素(Hfgl2)在宫颈癌组织中的表达及其意义,探究其对宫颈癌恶性生物学行为的影响。方法选取2016年1月至2018年1月在榆林市第一医院经病理确诊的50例宫颈癌患者的癌组织标本作为实验组,另外收集同期50例正常宫颈组织作为对照组。采用免疫组化和逆转录聚合酶链反应(RT-PCR)检测组织,蛋白质印迹法(WB)检测细胞中Hfgl2的表达,分析其与宫颈癌临床病理特征的关系;采用基因敲降下调Hfgl2表达,四甲基偶氮唑盐比色法(MTT)检测细胞增殖能力,WB方法检测血管生成及细胞增殖、迁移相关蛋白的表达。结果Hfgl2在宫颈癌组织中的阳性表达率高于正常宫颈组织,差异有统计学意义(χ^(2)=73.990,P<0.05);Hfgl2在宫颈癌组织的免疫组化评分高于正常宫颈组织,差异有统计学意义(t=8.022,P<0.05);RT-PCR测定表明,实验组Hfgl2 mRNA阳性表达率高于对照组,差异有统计学意义(χ^(2)=61.455,P<0.05);Hfgl2在宫颈癌国际妇产科联盟(FIGO)分期Ⅲ-Ⅳ期中的阳性表达率高于Ⅰ期、Ⅱ期组,在病理分级G2-G3级宫颈癌组的阳性表达率高于G1级组,在有淋巴转移的宫颈癌组织中阳性表达率高于无淋巴结转移组,差异均有统计学意义(χ^(2)值分别为6.737、7.147、12.037,P<0.05);Hfgl2在宫颈癌细胞系中均高表达,敲降Hfgl2后,细胞体外增殖能力明显降低,人宫颈癌细胞Hela血管生成及增殖迁移相关蛋白如血管内皮生长因子受体1(VEGFR1)、蛋白激酶B(PKB/Akt)、磷脂酶C(PLC)-γ、基质金属蛋白酶(MMP)2和MMP9表达均明显下调,差异有统计学意义(t值介于4.904~8.304之间,P<0.05)。结论Hfgl2在宫颈癌组织中高表达且可能促进肿瘤血管生成及浸润生长,有望成为宫颈癌靶向治疗新方向。 展开更多
关键词 人纤维介素 宫颈癌 临床病理特征 血管生成 增殖迁移
下载PDF
抑制SHP2和FGFR2调控RAS/ERK及PI3K/AKT通路治疗FGFR2融合胃癌
9
作者 张玥 汪越 +3 位作者 魏禹焘 禹立霞 刘宝瑞 魏嘉 《中国肿瘤临床》 CAS CSCD 北大核心 2024年第14期703-709,共7页
目的:探究共抑制成纤维细胞生长因子受体2(fibroblast growth factor receptor 2,FGFR2)和Src同源2结构域的蛋白酪氨酸磷酸酶2(Src homology region 2-containing protein tyrosine phosphatase 2,SHP2)在FGFR2融合胃癌中的应用前景与... 目的:探究共抑制成纤维细胞生长因子受体2(fibroblast growth factor receptor 2,FGFR2)和Src同源2结构域的蛋白酪氨酸磷酸酶2(Src homology region 2-containing protein tyrosine phosphatase 2,SHP2)在FGFR2融合胃癌中的应用前景与作用机制。方法:构建过表达TACC2-FGFR2融合基因与对照慢病毒载体的人胃癌细胞系MKN45ACC2T-FGFR2、MKN45NC、NUGC4TACC2-FGFR2、NUGC4NC,分别用FGFR2抑制剂AZD4547、SHP2抑制剂SHP099或联药进行处理,通过细胞计数试剂盒(CCK-8)、划痕实验检测肿瘤细胞的增殖、迁移能力。以不同处理方式作用于MKN45TACC2-FGFR2、MKN45NC1 h或48 h后,采用Western blot法检测FGFR2、SHP2以及下游RAS/ERK、PI3K/AKT信号通路变化。结果:在MKN45TACC2-FGFR2与NUGC4TACC2-FGFR2中联用AZD4547与SHP099可以比单药更显著地抑制肿瘤细胞的增殖与迁移。药物处理1 h后,相较于AZD4547单药,联药在MKN45TACC2-FGFR2中进一步抑制了RAS/ERK、PI3K/AKT信号通路。药物处理48 h与1 h相比,AZD4547单药组中磷酸化FGFR与磷酸化SHP2出现了反馈性激活,且始终不能抑制RAS/ERK通路,但联药组可以持续地抑制上游的FGFR2、SHP2信号以及下游的RAS/ERK、PI3K/AKT通路。结论:共抑制FGFR2和SHP2可以通过下调RAS/ERK及PI3K/AKT通路有效抑制FGFR2融合胃癌,为FG-FR2融合突变胃癌患者带来新的治疗模式。 展开更多
关键词 胃癌 靶向治疗 融合基因 纤维细胞生长因子受体2 Src同源2结构域的蛋白酪氨酸磷酸酶2
下载PDF
Effects of microtubule-associated protein tau expression on neural stem cell migration after spinal cord injury 被引量:6
10
作者 Zhi-ping Qi Guo-xiang Wang +4 位作者 Peng Xia Ting-ting Hou Hong-li Zhou Tie-jun Wang Xiao-yu Yang 《Neural Regeneration Research》 SCIE CAS CSCD 2016年第2期332-337,共6页
Our preliminary proteomics analysis suggested that expression of microtubule-associated protein tau is elevated in the spinal cord after injury. Therefore, the first aim of the present study was to examine tau express... Our preliminary proteomics analysis suggested that expression of microtubule-associated protein tau is elevated in the spinal cord after injury. Therefore, the first aim of the present study was to examine tau expression in the injured spinal cord. The second aim was to determine whether tau can regulate neural stem cell migration, a critical factor in the successful treatment of spinal cord injury. We established rat models of spinal cord injury and injected them with mouse hippocampal neural stem cells through the tail vein. We used immunohistochemistry to show that the expression of tau protein and the number of migrated neural stem cells were markedly increased in the injured spinal cord. Furthermore, using a Transwell assay, we showed that neural stem cell migration was not affected by an elevated tau concentration in the outer chamber, but it was decreased by changes in intracellular tau phosphorylation state. These results demonstrate that neural stem cells have targeted migration capability at the site of injury, and that although tau is not a chemokine for targeted migration of neural stem cells, intracellular tau phosphorylation/dephosphorylation can inhibit cell migration. 展开更多
关键词 nerve regeneration spinal cord injury tau protein neural stem cells transwelI chambers phosphatase 2a cell transplantation PHOSPHORYLATION migration okadaic acid C2-ceramide neural regeneration
下载PDF
HPV16 E6调控miR-23a表达促进宫颈癌细胞侵袭、迁移 被引量:1
11
作者 王敏 母丹 +3 位作者 孔德军 杨莉 叶璐 贺丹 《实用医学杂志》 CAS 北大核心 2024年第2期146-152,共7页
目的探讨高危型人乳头瘤病毒16 E6蛋白(HPV16 E6蛋白)调控miR-23a表达对宫颈癌细胞SiHa侵袭、迁移的作用。方法选取100例宫颈癌HPV阴性患者、100例HPV阳性患者的组织标本、100例癌旁正常组织;宫颈癌SiHa细胞分为空白组、E6过表达组、阴... 目的探讨高危型人乳头瘤病毒16 E6蛋白(HPV16 E6蛋白)调控miR-23a表达对宫颈癌细胞SiHa侵袭、迁移的作用。方法选取100例宫颈癌HPV阴性患者、100例HPV阳性患者的组织标本、100例癌旁正常组织;宫颈癌SiHa细胞分为空白组、E6过表达组、阴性转染组、E6+miR-23a mimics组;qRTPCR法检测miR-23a、HPV16 E6 mRNA表达;MTT法检测增殖抑制率;流式细胞仪检测凋亡;Transwell小室实验检测细胞侵袭;划痕实验检测细胞迁移;WB检测HPV16 E6、凋亡相关蛋白(Caspase-3、Bax、Bcl-2)、迁移相关蛋白(MMP-2、MMP-9)的表达。结果宫颈癌组织中miR-23a表达降低,其中宫颈癌HPV阳性组织中miR-23a表达水平更低。E6过表达降低miR-23a表达水平、细胞增殖抑制率、凋亡率、Caspase-3、Bax蛋白表达,增高Bcl-2蛋白、划痕愈合率、侵袭细胞数、MMP-2、MMP-9蛋白表达(P<0.05);miR-23a mimics逆转了E6过表达对上述各项指标的影响。结论HPV16 E6促进宫颈癌细胞侵袭、迁移可能与调控miR-23a表达有关。 展开更多
关键词 人乳头瘤病毒16 E6蛋白 miR-23a 宫颈癌 侵袭 迁移
下载PDF
G蛋白β2亚基对结直肠癌细胞转移能力的影响
12
作者 刘荣 王永霞 《新乡医学院学报》 CAS 2024年第7期619-624,630,共7页
目的探讨G蛋白β2亚基(GNB2)对结直肠癌细胞体外迁移和体内转移能力的影响及机制。方法将对数生长期人胚肾细胞293FT随机分为对照组和shGNB2组,对照组293FT细胞转染PSPAX2、PMD2G、Control质粒,shGNB2组293FT细胞转染PSPAX2、PMD2G、shG... 目的探讨G蛋白β2亚基(GNB2)对结直肠癌细胞体外迁移和体内转移能力的影响及机制。方法将对数生长期人胚肾细胞293FT随机分为对照组和shGNB2组,对照组293FT细胞转染PSPAX2、PMD2G、Control质粒,shGNB2组293FT细胞转染PSPAX2、PMD2G、shGNB2质粒,分别收集病毒上清液。将对数生长期人结直肠癌细胞HCT116、RKO按随机数字表法分为对照组和shGNB2组,应用293FT细胞对照组病毒上清液转染对照组HCT116和RKO细胞,应用293FT细胞shGNB2组病毒上清液转染shGNB2组HCT116和RKO细胞,应用实时荧光定量聚合酶链反应法检测对照组和shGNB2组HCT116、RKO细胞中GNB2 mRNA的表达,Western blot法检测对照组和shGNB2组HCT116、RKO细胞中GNB2、波形蛋白(Vimentin)、神经钙黏蛋白(N-cadherin)和E-钙黏蛋白(E-cadherin)的表达,划痕愈合实验检测对照组和shGNB2组HCT116、RKO细胞划痕愈合率,Transwell小室实验检测对照组和shGNB2组HCT116、RKO细胞迁移细胞数。分别取对照组和shGNB2组HCT116细胞2×106个注射于裸鼠皮下,3周后取出皮下肿瘤,剪成1 mm 3大小的组织块。按随机数字表法将8只4~5周龄雌性裸鼠分为对照组和shGNB2组,每组4只;将对照组HCT116细胞皮下瘤组织块接种于对照组裸鼠回盲部肠浆膜处,shGNB2组HCT116细胞皮下瘤组织块接种于shGNB2组裸鼠回盲部肠浆膜处;记录裸鼠死亡时间,取出肝脏,观察肝脏肿瘤转移数。结果shGNB2组HCT116、RKO细胞中GNB2 mRNA和蛋白相对表达量显著低于对照组(P<0.01)。培养48 h时,shGNB2组HCT116、RKO细胞划痕愈合率显著低于对照组(P<0.01),shGNB2组HCT116、RKO细胞迁移数显著少于对照组(P<0.01)。shGNB2组裸鼠肝内转移瘤数显著少于对照组(P<0.05)。shGNB2组HCT116、RKO细胞中Vimentin、N-cadherin蛋白相对表达量显著低于对照组,E-cadherin蛋白相对表达量显著高于对照组(P<0.01)。结论干扰GNB2表达可有效抑制结直肠癌细胞的转移能力,其机制可能是GNB2通过调控上皮间质转化过程来参与结直肠癌细胞的转移。 展开更多
关键词 结直肠癌 G蛋白β2亚基 迁移 转移
下载PDF
宫颈癌患者lncRNA HAND2-AS1表达及其对宫颈癌Caski细胞增殖、侵袭和迁移能力的影响 被引量:1
13
作者 张晓科 褚艳荣 +1 位作者 王荣 崔发财 《检验医学》 CAS 2024年第5期429-437,共9页
目的探讨宫颈癌患者血清长链非编码RNA(lncRNA)心脏和神经嵴衍生物表达转录本2反义序列1(HAND2-AS1)表达的临床意义,分析lncRNA HAND2-AS1对宫颈癌Caski细胞增殖、侵袭和迁移的影响机制。方法采用基因表达交互分析(GEPIA)数据库分析lncR... 目的探讨宫颈癌患者血清长链非编码RNA(lncRNA)心脏和神经嵴衍生物表达转录本2反义序列1(HAND2-AS1)表达的临床意义,分析lncRNA HAND2-AS1对宫颈癌Caski细胞增殖、侵袭和迁移的影响机制。方法采用基因表达交互分析(GEPIA)数据库分析lncRNA HAND2-AS1在宫颈癌组织和正常宫颈组织中的表达情况。选取2019年1月—2021年12月焦作市妇幼保健院宫颈癌患者48例(宫颈癌组)、宫颈上皮内瘤变(CIN)患者48例(CIN组)和健康体检者48名(正常对照组)。收集其中14例宫颈癌患者术后癌组织和癌旁组织(距癌组织边缘>2 cm)样本,同时收集所有研究对象血清样本和临床资料,检测lncRNA HAND2-AS1相对表达量。将宫颈癌细胞系Caski按转染质粒的不同分为过表达组(转染pcDNA3.1-HAND2-AS1)和阴性对照组(转染pcDNA3.1-NC)、干扰组(转染si-HAND2-AS1)和干扰对照组(转染si-NC)。采用CCK-8实验、Transwell实验和划痕实验检测细胞的增殖、侵袭和迁移能力,采用免疫印迹法检测细胞内磷脂酰肌醇3-激酶(PI3K)、磷酸化磷脂酰肌醇3-激酶(p-PI3K)、蛋白激酶B(Akt)和磷酸化蛋白激酶B(p-Akt)的表达情况。结果GEPIA数据库分析结果显示,宫颈癌组织lncRNA HAND2-AS1表达显著低于正常宫颈上皮组织(P<0.05)。14例宫颈癌患者癌组织lncRNA HAND2-AS1相对表达量显著低于癌旁组织(P=0.001)。宫颈癌组血清lncRNA HAND2-AS1相对表达量显著低于CIN组和正常对照组(P<0.001),CIN组与正常对照组之间差异无统计学意义(P>0.05)。不同肿瘤大小、国际妇产科学联合会(FIGO)分期和有无淋巴转移的宫颈癌患者之间血清lncRNA HAND2-AS1相对表达量差异均有统计学意义(P<0.05)。过表达组lncRNA HAND2-AS1相对表达量显著高于阴性对照组(P<0.01),细胞增殖活性、侵袭细胞数、划痕愈合率和p-PI3K、p-Akt蛋白相对表达量均低于阴性对照组(P<0.05)。干扰组lncRNA HAND2-AS1相对表达量显著低于干扰对照组(P<0.001),细胞增殖活性、侵袭细胞数、划痕愈合率和p-PI3K、p-Akt蛋白相对表达量均显著高于干扰对照组(P<0.05)。过表达组与阴性对照组之间、干扰组与干扰对照组之间PI3K和Akt蛋白相对表达量差异均无统计学意义(P>0.05)。结论宫颈癌患者血清lncRNA HAND2-AS1呈低表达,且与病情严重程度有关。lncRNA HAND2-AS1可能通过调控PI3K/Akt信号通路影响宫颈癌细胞的增殖、侵袭和迁移。 展开更多
关键词 心脏和神经嵴衍生物表达转录本2反义序列1 长链非编码RNA 宫颈癌 侵袭 迁移
下载PDF
Mfn2调控VEGFR2/PI3K促进卵巢癌种植转移的机制研究
14
作者 郑翠 贾颖娜 +1 位作者 何慧 徐菁华 《分子诊断与治疗杂志》 2024年第3期548-552,共5页
目的 探讨线粒体融合蛋白2(Mfn2)对卵巢癌种植转移的作用以及其可能的分子机制。方法 选取2019年6月至2021年6月于南京医科大学附属苏州医院就诊治疗的86例卵巢癌患者作为研究对象,对比癌组织和癌旁组织Mfn2、血管内皮生长因子受体2(VEG... 目的 探讨线粒体融合蛋白2(Mfn2)对卵巢癌种植转移的作用以及其可能的分子机制。方法 选取2019年6月至2021年6月于南京医科大学附属苏州医院就诊治疗的86例卵巢癌患者作为研究对象,对比癌组织和癌旁组织Mfn2、血管内皮生长因子受体2(VEGFR2)、磷酸酰肌醇3激酶(PI3K)蛋白表达,分析Mfn2、VEGFR2、PI3K蛋白表达与相关病理特征的关系。构建Mfn2上调/下调卵巢癌SKOV-3细胞株并验证Mfn2、VEGFR2、PI3K的表达。结果 Mfn2、VEGFR2、PI3K在肿瘤组织中的阳性表达率高于癌旁组织,差异均有统计学意义(χ^(2)=4.597、6.456、3.930,P=0.032、0.011、0.047);不同FIGO分期、淋巴结转移、远处转移情况及生存情况中,卵巢组织中Mfn2、VEGFR2、PI3K蛋白表达比较,差异均有统计学意义(P<0.05)。与NC组对比,Mfn2上调组卵巢癌SKOV-3细胞中Mfn2 mRNA相对表达量和Mfn2、VEGFR2、PI3K蛋白、显著上调(P<0.05);与shNC组对比,shMfn2下调组卵巢癌SKOV-3细胞中Mfn2mRNA相对表达量和Mfn2、VEGFR2、PI3K蛋白显著下调(P<0.05)。结论 下调Mfn2表达与VEGFR2、PI3K表达水平可以预防卵巢癌种植转移。 展开更多
关键词 卵巢癌 线粒体融合蛋白2 血管内皮生长因子受体2 磷酸酰肌醇3激酶 细胞迁移
下载PDF
乳腺癌组织中PTEN、MMP-2、AKT的表达及其与临床病理特征的相关性
15
作者 邓亚萍 荆海红 吴瑜 《实用癌症杂志》 2024年第10期1611-1613,共3页
目的探讨乳腺癌组织内第10号染色体缺失的磷酸酶和张力蛋白同源基因(PTEN)、基质金属蛋白酶-2(MMP-2)、蛋白激酶B(AKT)的表达及其与患者临床病理特征间的关系。方法选取63例乳腺癌患者,收集其癌组织与癌旁正常组织(距离病灶边缘≥3 cm)... 目的探讨乳腺癌组织内第10号染色体缺失的磷酸酶和张力蛋白同源基因(PTEN)、基质金属蛋白酶-2(MMP-2)、蛋白激酶B(AKT)的表达及其与患者临床病理特征间的关系。方法选取63例乳腺癌患者,收集其癌组织与癌旁正常组织(距离病灶边缘≥3 cm),以免疫组织化学法测定组织内PTEN、MMP-2、AKT表达。收集患者的年龄、性别等资料,分析PTEN、MMP-2、AKT表达与患者临床病理特征间的关系。结果癌组织中的MMP-2、AKT阳性表达率高于癌旁组织,PTEN阳性表达率低于癌旁组织,有统计学差异(P<0.05)。PTEN、MMP-2、AKT表达与乳腺癌患者的年龄、肿瘤部位无关(P>0.05);与患者肿瘤的组织学分级、淋巴结转移有关(P<0.05)。结论PTEN、MMP-2、AKT在乳腺癌组织内呈异常表达,其表达与肿瘤的组织学分级、淋巴结转移有关。 展开更多
关键词 乳腺癌 第10号染色体缺失的磷酸酶和张力蛋白同源基因 基质金属蛋白酶-2 蛋白激酶B 临床病理特征
下载PDF
澳洲茄碱通过调控Bcl-2/Bax/caspase-3信号通路促进非小细胞肺癌发生凋亡
16
作者 陈桂玲 廖晓凤 +4 位作者 孙鹏涛 岑欢 舒盛春 李碧晶 黎金华 《南方医科大学学报》 CAS CSCD 北大核心 2024年第6期1109-1116,共8页
目的 探讨龙葵活性成分澳洲茄碱对非小细胞肺癌细胞PC9增殖、凋亡的影响。方法 体外培养PC9细胞,设对照组(0μmol/L)及澳洲茄碱不同剂量组(0、2、5、10、15、20、25μmol/L),CCK-8试剂盒检测澳洲茄碱对PC9细胞的增殖抑制作用;TMRE检测... 目的 探讨龙葵活性成分澳洲茄碱对非小细胞肺癌细胞PC9增殖、凋亡的影响。方法 体外培养PC9细胞,设对照组(0μmol/L)及澳洲茄碱不同剂量组(0、2、5、10、15、20、25μmol/L),CCK-8试剂盒检测澳洲茄碱对PC9细胞的增殖抑制作用;TMRE检测线粒膜电位;caspase3/7活性试剂盒联合GreenNuc?Caspase-3/Annexin V-mCherry染色检测caspase-3活性;Annexin V-FITC/PI双染法检测细胞凋亡率;给药处理或者使用PTEN抑制剂后,Western blot检测细胞中相关蛋白的表达量。结果 与对照组相比,经澳洲茄碱干预24、48、72 h后,PC9细胞的活力均明显降低(P<0.05);经澳洲茄碱干预24 h后,细胞线粒体膜电位明显降低,而细胞凋亡比例明显升高(P<0.05);caspase-3/7活力、活细胞Caspase-3活性及cleaved caspase-3蛋白表达均显著升高(P<0.01);PI3K和Akt磷酸化水平降低(P<0.05);而PTEN、Bax蛋白表达上调(P<0.05);抗凋亡蛋白Bcl-2蛋白的表达下调(P<0.05)。结论 澳洲茄碱可通过调控Bcl-2/Bax/caspase-3通路及其上游蛋白活性而抑制PC9细胞增殖,促进其凋亡。 展开更多
关键词 澳洲茄碱 肺癌 Bcl-2/Bax/caspase-3通路 同源性磷酸酶-张力蛋白 细胞凋亡
下载PDF
生物信息学技术分析人结直肠癌中蛋白磷酸酶2A催化亚基α(PPP2CA)表达与患者预后及免疫浸润的关系
17
作者 梁小洁 程照翔 +2 位作者 尚维伟 陈信浩 李俊 《细胞与分子免疫学杂志》 CAS CSCD 北大核心 2024年第7期591-604,共14页
目的通过分析蛋白磷酸酶2A催化亚基α(PPP2CA)在结直肠癌(CRC)中表达水平与患者预后及免疫浸润的关系,进一步了解CRC发生和进展中的相关机制。方法基于基因芯片数据库Oncomine和肿瘤免疫评估资源(TIMER)数据库分析在CRC组织和正常组织中... 目的通过分析蛋白磷酸酶2A催化亚基α(PPP2CA)在结直肠癌(CRC)中表达水平与患者预后及免疫浸润的关系,进一步了解CRC发生和进展中的相关机制。方法基于基因芯片数据库Oncomine和肿瘤免疫评估资源(TIMER)数据库分析在CRC组织和正常组织中PPP2CA表达水平的差异性;基于阿拉巴马大学伯明翰分校癌症数据分析门户(UALCAN)和基因表达谱交互分析(GEPIA)数据库分析PPP2CA的表达水平对CRC患者预后的影响;基于LinkedOmics平台构建PPP2CA的共表达网络并进行基因本体论(GO)富集分析和京东基因和基因组百科全书(KEGG)通路分析;基于TIMER和GEPIA数据库分析PPP2CA与免疫浸润之间的相关性。基于c-BioPortal平台分析结肠腺癌(COAD)中PPP2CA的基因突变情况。结果与正常结直肠组织相比,在CRC组织中PPP2CA表达下调。高表达水平的PPP2CA预示着更好的总生存期(OS)和无进展生存期(PFS)。在COAD中,PPP2CA的表达水平与包括CD8^(+)T细胞、中性粒细胞和树突状细胞在内的免疫浸润细胞呈正相关。而某些免疫细胞标志物,包括B细胞的CD19和CD38、M1巨噬细胞的一氧化氮合酶2(NOS2)、M2巨噬细胞的精氨酸酶1(Arg1)和甘露糖受体C1(MRC1)、肿瘤相关巨噬细胞(TAM)的人类白细胞抗原G(HLA-G)和CD80、单核细胞的CD14和IgG Fc段受体Ⅲa(FCGR3A),却显示出不同的PPP2CA相关免疫浸润模式:即PPP2CA表达水平与COAD和直肠腺癌(READ)中的B细胞、巨噬细胞、单核细胞、TAM、1型辅助T(Th1)细胞、Th2细胞、调节性T细胞、衰竭T细胞和中性粒细胞均显著相关。结论PPP2CA在CRC组织表达水平下调,并且与免疫浸润密切相关。 展开更多
关键词 蛋白磷酸酶2a催化亚基α基因(PPP2CA) 结直肠癌(CRC) 免疫浸润 预后
下载PDF
宫颈癌术前血清MAP19、OPN、AGR2水平及其预测术后2年内复发价值
18
作者 崔永魁 刘瑶玮 吕玲 《中国计划生育学杂志》 2024年第4期903-907,共5页
目的:探讨宫颈癌术后复发的危险因素及甘露聚糖结合凝集素相关蛋白19(MAP19)、骨桥蛋白(OPN)、前梯度蛋白2(AGR2)的预测价值。方法:收集2016年1月-2021年1月本院诊治的宫颈癌患者250例临床资料,随访术后2年发生复发情况分为复发组(n=32)... 目的:探讨宫颈癌术后复发的危险因素及甘露聚糖结合凝集素相关蛋白19(MAP19)、骨桥蛋白(OPN)、前梯度蛋白2(AGR2)的预测价值。方法:收集2016年1月-2021年1月本院诊治的宫颈癌患者250例临床资料,随访术后2年发生复发情况分为复发组(n=32),未复发者为未复发组(n=218),收集患者临床资料,分析宫颈癌术后复发的危险因素,检测血清MAP19、OPN、AGR2水平并采用受试者工作特征(ROC)曲线分析预测术后复发价值。结果:两组肿瘤直径、分化程度、肿瘤间质浸润、FIGO分期、淋巴结转移有差异,复发组血清MAP19(266.04±80.21μg/L)、OPN(61.25±20.14μg/L)、AGR2(12.44±3.14 ng/ml)水平高于未复发组(138.25±56.73μg/L、19.45±3.56μg/L、12.44±3.14 ng/ml),多因素非条件logistic分析,肿瘤直径≥4 cm、分化程度高分化、肿瘤间质浸润深肌层、FIGO分期IA1~IA2、淋巴结转移,以及MAP19、OPN、AGR2高水平均是宫颈癌术后复发的独立危险因素(均P<0.05);ROC分析显示,预测宫颈癌术后复发血清MAP19的曲线下面积(AUC)为0.702,灵敏度73.2%,特异度80.1%,截断值186.54μg/L;血清OPN的AUC为0.825,灵敏度76.4%,特异度82.5%,截断值34.76μg/L;血清AGR2的AUC为0.727,灵敏度74.6%,特异度79.8%,截断值7.46ng/ml。结论:宫颈癌术后复发患者术前血清MAP19、OPN、AGR2水平异常升高,是宫颈癌术后复发独立危险因素,且对预测宫颈癌术后2年内的复发有一定参考价值。 展开更多
关键词 宫颈癌 甘露聚糖结合凝集素相关蛋白19 骨桥蛋白 前梯度蛋白2 危险因素 术后复发 预测价值
下载PDF
敲减SATB2抑制乳腺癌细胞的增殖、迁移、侵袭和血管生成 被引量:2
19
作者 吴坤琳 严乾壹 +2 位作者 王德星 缪秀英 张惠灏 《中国病理生理杂志》 CAS CSCD 北大核心 2023年第11期1994-2002,共9页
目的:探讨特异AT富含序列结合蛋白2(SATB2)在乳腺癌中的作用,并分析敲减SATB2对乳腺癌细胞恶性生物学行为的影响和潜在机制。方法:用GEPIA数据库分析SATB2在乳腺癌中的表达,用Kaplan-Meier Plotter数据库分析其对乳腺癌患者总生存期(OS... 目的:探讨特异AT富含序列结合蛋白2(SATB2)在乳腺癌中的作用,并分析敲减SATB2对乳腺癌细胞恶性生物学行为的影响和潜在机制。方法:用GEPIA数据库分析SATB2在乳腺癌中的表达,用Kaplan-Meier Plotter数据库分析其对乳腺癌患者总生存期(OS)的影响。免疫组化检测乳腺癌组织中SATB2的蛋白表达。将人乳腺癌细胞株MDA-MB-231与MCF-7分为si-Con组(转染si-Con)和si-SATB2组(转染si-SATB2)。用EdU染色和集落形成实验评估细胞增殖能力,用Transwell方法检测乳腺癌细胞的迁移、侵袭能力及其对内皮细胞的招募能力,用小管形成实验检测其诱导内皮细胞血管生成能力,Western blot检测血管内皮生长因子A(VEGFA)、基质金属蛋白酶2(MMP-2)、MMP-9、激活STAT蛋白抑制因子1(PIAS1)和组蛋白脱乙酰基酶1(HDAC1)的表达。结果:与正常乳腺组织比较,乳腺癌中SATB2的基因和蛋白水平均升高(P<0.05)。与SATB2低表达组比较,SATB2高表达组的乳腺癌患者的OS显著缩短(P<0.05)。与si-Con组比较,si-SATB2组乳腺癌细胞的增殖、迁移和侵袭及招募内皮细胞和诱导血管形成能力均降低(P<0.05);乳腺癌细胞中VEGFA、MMP-2、MMP-9、PIAS1和HDAC1表达均下调(P<0.05)。结论:敲减SATB2能抑制乳腺癌细胞的增殖、迁移、侵袭和肿瘤血管生成,其机制可能与其抑制VEGFA、MMP-2、MMP-9、PIAS1和HDAC1表达有关。 展开更多
关键词 特异AT富含序列结合蛋白2 乳腺癌 细胞迁移 细胞侵袭 血管生成
下载PDF
宫颈癌患者血清S100A14和LOXL2的表达水平及临床意义 被引量:2
20
作者 李彦英 黄平 +3 位作者 张治 肖喜云 张玲 刘丹彤 《国际检验医学杂志》 CAS 2023年第1期40-43,48,共5页
目的探讨宫颈癌患者血清S100钙离子结合蛋白A14(S100A14)和赖氨酰氧化酶样蛋白2(LOXL2)的表达水平及临床意义。方法选取2019年9月至2021年6月该院治疗的84例宫颈癌患者(宫颈癌组)、90例宫颈上皮瘤变患者(宫颈上皮瘤变组)以及同期在该院... 目的探讨宫颈癌患者血清S100钙离子结合蛋白A14(S100A14)和赖氨酰氧化酶样蛋白2(LOXL2)的表达水平及临床意义。方法选取2019年9月至2021年6月该院治疗的84例宫颈癌患者(宫颈癌组)、90例宫颈上皮瘤变患者(宫颈上皮瘤变组)以及同期在该院健康体检的80例健康女性(健康对照组)。用酶联免疫吸附试验(ELISA)检测血清S100A14和LOXL2的表达水平。绘制受试者工作特征(ROC)曲线,分析血清S100A14和LOXL2诊断及鉴别诊断宫颈癌的价值,计算曲线下面积(AUC)。分析血清S100A14、LOXL2表达水平与宫颈癌临床病理特征的关系。结果宫颈癌组血清S100A14和LOXL2表达水平均高于宫颈上皮瘤变组及健康对照组,差异有统计学意义(P<0.05),宫颈上皮瘤变组血清S100A14和LOXL2表达水平均高于健康对照组,差异有统计学意义(P<0.05)。血清S100A14、LOXL2诊断宫颈癌的AUC分别为0.895和0.929,鉴别诊断宫颈癌的AUC分别为0.744和0.833。宫颈癌患者血清S100A14与LOXL2呈正相关(r=0.239,P<0.05)。TNM分期为Ⅲ~Ⅳ期、高分化、肿瘤最大径≥4 cm、浸润深度≥1/2肌层、淋巴结转移宫颈癌患者的血清S100A14、LOXL2表达水平均高于TNM分期为Ⅰ~Ⅱ期、中低分化、肿瘤最大径<4 cm、浸润深度<1/2肌层、淋巴结未转移宫颈癌患者(P<0.05)。血清S100A14、LOXL2分别与宫颈癌TNM分期呈正相关(P<0.05)。结论血清S100A14和LOXL2对宫颈癌的早期诊断及病情评估有一定价值。 展开更多
关键词 宫颈癌 诊断 血清 S100钙离子结合蛋白A14 赖氨酰氧化酶样蛋白2
下载PDF
上一页 1 2 10 下一页 到第
使用帮助 返回顶部